Peter Kaiser is Chief Development Officer of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 207,104 shares of OCUL, which is worth approximately $1.63 Million. The most recent transaction as insider was on May 23, 2025, when has been sold 2,974 shares (Common Stock) at a price of $7.17 per share, resulting in proceeds of $21,323. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 207K
1.42% 3M change
n/a 12M change
Total Value Held $1.63 Million

Peter Kaiser Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 23 2025
SELL
Open market or private sale
$21,323 $7.17 p/Share
2,974 Reduced 1.42%
207,104 Common Stock
Feb 24 2025
SELL
Open market or private sale
$20,671 $6.87 p/Share
3,009 Reduced 1.41%
210,078 Common Stock
Nov 25 2024
SELL
Open market or private sale
$26,101 $9.01 p/Share
2,897 Reduced 1.34%
213,087 Common Stock
Oct 02 2024
BUY
Grant, award, or other acquisition
-
100,000 Added 31.65%
215,984 Common Stock
PK

Peter Kaiser

Chief Development Officer
Bedford, MA

Track Institutional and Insider Activities on OCUL

Follow OCULAR THERAPEUTIX, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUL shares.

Notify only if

Insider Trading

Get notified when an Ocular Therapeutix, Inc insider buys or sells OCUL shares.

Notify only if

News

Receive news related to OCULAR THERAPEUTIX, INC

Track Activities on OCUL